This comprehensive economic analysis quantifies the indirect costs of cancer-related premature mortality across eight European countries, examining both macroeconomic burden and behavioural intervention pathways for cancer risk reduction. The research employs quantitative methodologies to assess productivity losses, fiscal revenue impacts, and policy intervention effectiveness within the framework of the 4P-CAN Horizon Europe project on personalized cancer primary prevention